Sep 25, 2017
The American Society for Microbiology (ASM) has selected Nicholas Restifo, M.D., Senior Investigator in the Surgery Branch, to receive the 2018 ASM Award in Clinical and Diagnostic Immunology. The award recognizes scientists for their outstanding contributions to microbiology in service of science and the public. Learn more…
CCR’s Douglas Lowy and John Schiller receive the 2017 Lasker~DeBakey Clinical Medical Research Award
Sep 6, 2017
Douglas Lowy, M.D., and John Schiller, Ph.D., of CCR’s Laboratory of Cellular Oncology have received the 2017 Lasker~DeBakey Clinical Medical Research Award for their groundbreaking research leading to the development of human papillomavirus (HPV) vaccines. The Lasker Awards are widely regarded as the country’s most prestigious biomedical research prizes.
Aug 29, 2017
The Biophysical Society has selected Sriram Subramaniam, Ph.D., Senior Investigator in the Laboratory of Cell Biology, as a 2018 Fellow for his seminal contributions to the cryo-EM field and related disciplines, including electron tomography and focused ion beam imaging. Along with other distinguished members who have demonstrated excellence in science and contributed to the expansion of the field of biophysics, Dr. Subramaniam will be honored during the Awards Ceremony of the Biophysical Society’s Annual Meeting on February 19, 2018 in San Francisco. Learn more...
Aug 16, 2017
Kevin Camphausen, M.D., Chief of CCR’s Radiation Oncology Branch, is among 23 distinguished members of the American Society for Radiation Oncology (ASTRO) to receive fellowship designation. Since 2006, the ASTRO Fellowship has been awarded to physicians and medical physicists making significant contributions to the field of radiation oncology in research, patient care, education and leadership. Dr. Camphausen will receive his award during ASTRO’s Annual Meeting, held September 24-27, 2017, in San Diego.
Aug 9, 2017
Freddie Escorcia, M.D., Ph.D., has been appointed as an Assistant Clinical Investigator in the Molecular Imaging Program (MIP). Dr. Escorcia's work focuses on tumor-targeted, personalized cancer treatment. Targeted radionuclide therapy provides an orthogonal mode of cell killing that is distinct from, yet complementary to, existing small molecule and chemotherapy treatments. Learn more...
Jul 27, 2017
Anish Thomas, M.D., of CCR’s Developmental Therapeutics Branch, has been appointed as an NIH Lasker Scholar Tenure Track Investigator. Dr. Thomas is involved in translational clinical trials focusing on lung cancer, mesothelioma and thymic cancers. His research interests include chemotherapy resistance and the use of synthetic lethal approaches against DNA damage response pathways, immunotherapy of thoracic cancers, predictive markers for response to biologic therapy, the cancer drug development process and clinical trial design.
Jul 13, 2017
Three CCR researchers, Stephanie Harmon, Ph.D., Fatima Karzai, M.D., and David VanderWeele, M.D., Ph.D., received 2017 Young Investigator Awards from the Prostate Cancer Foundation on July 10, 2017. The Young Investigator Awards support early-career scientists who are researching promising therapies for prostate cancer.
POB/JHU trainee awarded Teaching Fellow of the Year
Jun 29, 2017
Julia Cohen, M.D., from the Pediatric Oncology Branch (POB), received the Teaching Fellow of the Year award from the Johns Hopkins Hospital house staff. Julia is a Pediatric Hematology/Oncology fellow; a joint program of the POB and Johns Hopkins University. Fellows receive combined clinical training during their first year at both Johns Hopkins Hospital and the NIH Clinical Center. Nirali Shah, M.D., Staff Clinician in POB, said, “This is a huge testament to her kind, caring nature and compassion with which she treats everyone.”
Jun 8, 2017
Mark Roschewski, M.D., Staff Clinician in CCR’s Lymphoid Malignancies Branch, received the Research Physician of the Year award from the Physicians Professional Advisory Committee to the Surgeon General of the U.S. Public Health Service. According to the website, this award “recognizes individual initiative, accomplishment, and accountability for actions that increase the overall effectiveness of the HHS through research.” Bill Dahut, M.D., CCR Scientific Director for Clinical Research, says, “He has the unusual ability to combine the unique sensitivity of clinical research and patient care, which has impacted patients with life-devastating lymphomas.”
Jun 5, 2017
Amy LeBlanc, D.V.M., Director of the CCR Comparative Oncology Program, was featured in a joint PBS and Colorado State University documentary on comparative oncology. The documentary, “The Answer to Cancer Might be Walking Beside Us” highlights how researching cancer in dogs can lead to better cures and treatments for humans because dogs get cancer the same way people do.